LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.94 | 771.67 | 1045 | 1045 | 0.9999 | 0.9995 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 18.22 | 771.67 | 1714 | 1741 | 0.9843 | 0.9732 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 12.28 | 770.25 | 1277 | 1358 | 0.9403 | 0.8550 | MN20160304_L02 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.00 | 771.67 | 1595 | 1585 | 1.0060 | 1.0115 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 13.78 | 771.67 | 1440 | 1459 | 0.9865 | 0.9706 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 2.49 | 771.67 | 869 | 867 | 1.0014 | 1.0171 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 22.66 | 771.67 | 1889 | 2141 | 0.8821 | 0.8367 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 27.11 | 771.67 | 2131 | 2675 | 0.7966 | 0.7618 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 29.33 | 771.67 | 2368 | 2939 | 0.8056 | 0.7880 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.00 | 771.67 | 2852 | 3884 | 0.7342 | 0.7518 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.22 | 771.67 | 2995 | 4299 | 0.6966 | 0.7285 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 42.67 | 771.67 | 3462 | 5155 | 0.6715 | 0.7295 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 44.89 | 771.67 | 3751 | 5541 | 0.6769 | 0.7436 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 53.77 | 771.67 | 4682 | 7256 | 0.6452 | 0.7465 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 55.99 | 771.67 | 4853 | 7690 | 0.6311 | 0.7408 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 60.44 | 771.67 | 5307 | 8530 | 0.6221 | 0.7441 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 62.66 | 771.67 | 5519 | 8978 | 0.6147 | 0.7432 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.32 | 771.67 | 5955 | 10212 | 0.5831 | 0.7305 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.54 | 771.67 | 5982 | 10532 | 0.5679 | 0.7214 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.02 | 771.67 | 6115 | 11106 | 0.5506 | 0.7126 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.25 | 771.67 | 5962 | 11367 | 0.5245 | 0.6936 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 4.71 | 771.67 | 956 | 956 | 0.9996 | 0.9975 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 11.56 | 771.67 | 1265 | 1280 | 0.9878 | 0.9667 | MN20160304_L01 | C03 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 25.62 | 770.25 | 1615 | 2514 | 0.6422 | 0.5430 | MN20160304_L02 | C03 |
MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 23.39 | 770.25 | 1605 | 2244 | 0.7151 | 0.6093 | MN20160304_L02 | C03 |